Agree. There must have been a drop or it's over. That's not because of the dose level but because of the shrna transduction numbers IMO. I reckon PF's final nail was telling HC posters that cohort four has started.
PV1 Provaris tells ASX non-binding MOUs are still material to share prices in somewhat fiery compliance response